CollPlant Biotechnologies Ltd Share-based Payment Arrangement, Expense
CollPlant Biotechnologies Ltd (CLGN) reported Share-based Payment Arrangement, Expense of $1.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-03-26
- CollPlant Biotechnologies Ltd share-based payment arrangement, expense for the quarter ending 2025-06-30 was $356.00K, a 27.35% decline year-over-year.
- CollPlant Biotechnologies Ltd share-based payment arrangement, expense for the quarter ending 2024-06-30 was $490.00K, a 44.97% increase year-over-year.
- CollPlant Biotechnologies Ltd share-based payment arrangement, expense for the quarter ending 2023-06-30 was $338.00K.
- CollPlant Biotechnologies Ltd share-based payment arrangement, expense for the quarter ending 2020-06-30 was $477.00K, a 65.05% increase year-over-year.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $1.00M 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $356.00K 6-K · filed 2025-08-20 | $738.00K 6-K · filed 2025-08-20 | |
| 2024-12-31 | $1.72M 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $490.00K 6-K · filed 2025-08-20 | $780.00K 6-K · filed 2025-08-20 | |
| 2023-12-31 | $1.94M 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $338.00K 6-K · filed 2024-08-20 | $852.00K 6-K · filed 2024-08-20 | |
| 2022-12-31 | $2.17M 20-F · filed 2025-03-26 | ||
| 2022-06-30 | $1.05M 6-K · filed 2022-08-25 | ||
| 2021-12-31 | $1.62M 20-F · filed 2024-04-04 | ||
| 2021-06-30 | $954.00K 6-K · filed 2022-08-25 | ||
| 2020-12-31 | $1.67M 20-F · filed 2021-03-26 | ||
| 2020-06-30 | $477.00K 6-K · filed 2020-08-28 | $794.00K 6-K · filed 2021-08-19 | |
| 2019-12-31 | $1.13M 20-F · filed 2021-03-26 | ||
| 2019-06-30 | $289.00K 6-K · filed 2020-08-28 | $629.00K 6-K · filed 2020-08-28 | |
| 2018-12-31 | $1.43M 20-F · filed 2021-03-26 |